BLS Pharmaceuticals LimitedASX: BLS

BLS Investor Presentation

· Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX ·

A year of transformation, scale & international growth FY2026 FULL YEAR RESULTS ASX: BLS | August 2026 DISCLAIMER This presentation (Presentation) has been prepared by BLS Pharmaceuticals Limited ABN 97 084 464 193 (BLS or the Company).The information in this Presentation is of a...

View Attachment

6ix hasn’t read this filing yet.

BLS Pharmaceuticals Limited on 6ix

In the deck

Earlier from BLS Pharmaceuticals

Later from BLS Pharmaceuticals

All BLS Pharmaceuticals news releases